Chronic treatment with cannabinoid receptor agonist, CP 55,940,
Sandra A. Mitchell, CRNP, MScN, AOCN National Cancer Institute, Bethesda, MD
Chronic treatment with cannabinoid receptor agonist, CP 55,940, alters GLT1 expression in adolescent rats Introduction Methods Results Selected References.
INTERORGAN AMMONIA TRAFFICKING IN HEALTH AND DISEASE
Neurology_Medical_Newsletter_2011
02-13-12
Cognitive Dysfunction In Patients with a Primary Brain Tumor: Exploring and Navigating Uncharted Waters Sandra A. Mitchell, CRNP, MScN, AOCN National Cancer.
NON-NEURAXIAL TECHNIQUES FOR LABOR ANALGESIA
